eDruginfo.com - fexofenadine

Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Quik Tools

Drug Info Links

Drug Info Bookstore

Feedback

Registration

Disclaimer

fexofenadine
Allegra	Pharmaceutical company: Sanofi-Aventis www.sanofi-aventis.us

NEW INDICATION & DOSAGE
Relief of symptoms associated with seasonal allergic rhinitis in children ages 6 to 11 yrs with an orally disintegrating tablet--
Pediatric patients ages 6 to 11 years: 30 mg orally disintegrating tablet P.O. b.i.d.; place on tongue, allow to disintegrate, and then swallow with or without water.

Home - Guest Registry - Customer Service